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Abstract
Background: Pre-eclampsia has an immense adverse impact on maternal and perinatal health especially in low- and middle-
income settings. We aimed to estimate the associations between pre-eclampsia/eclampsia and its risk factors, and adverse
maternal and perinatal outcomes.
Methods:We performed a secondary analysis of the WHO Global Survey on Maternal and Perinatal Health. The survey was a
multi-country, facility-based cross-sectional study. A global sample consisting of 24 countries from three regions and 373
health facilities was obtained via a stratified multi-stage cluster sampling design. Maternal and offspring data were extracted
from records using standardized questionnaires. Multi-level logistic regression modelling was conducted with random
effects at the individual, facility and country levels.
Results: Data for 276,388 mothers and their infants was analysed. The prevalence of pre-eclampsia/eclampsia in the study
population was 10,754 (4%). At the individual level, sociodemographic characteristics of maternal age $30 years and low
educational attainment were significantly associated with higher risk of pre-eclampsia/eclampsia. As for clinical and
obstetric variables, high body mass index (BMI), nulliparity (AOR: 2.04; 95%CI 1.92–2.16), absence of antenatal care (AOR:
1.41; 95%CI 1.26–1.57), chronic hypertension (AOR: 7.75; 95%CI 6.77–8.87), gestational diabetes (AOR: 2.00; 95%CI 1.63–
2.45), cardiac or renal disease (AOR: 2.38; 95%CI 1.86–3.05), pyelonephritis or urinary tract infection (AOR: 1.13; 95%CI 1.03–
1.24) and severe anemia (AOR: 2.98; 95%CI 2.47–3.61) were found to be significant risk factors, while having .8 visits of
antenatal care was protective (AOR: 0.90; 95%CI 0.83–0.98). Pre-eclampsia/eclampsia was found to be a significant risk factor
for maternal death, perinatal death, preterm birth and low birthweight.
Conclusion: Chronic hypertension, obesity and severe anemia were the highest risk factors of preeclampsia/eclampsia.
Implementation of effective interventions prioritizing risk factors, provision of quality health services during pre-pregnancy
and during pregnancy for joint efforts in the areas of maternal health are recommended.
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Introduction
Pre-eclampsia has an immense adverse impact on maternal and
perinatal health, especially in the developing world. It is a major
cause of almost a third of a million maternal deaths in low- and
middle-income settings [1,2] and also accounts for substantial
proportions of the more than six million perinatal deaths [3],
approximately eight million preterm births [4] and almost 20
million low birthweight infants in developing nations [5].
Furthermore, pre-eclampsia and its adverse outcomes have been
linked to higher risks of chronic non-communicable diseases
(NCDs) in later life, thereby posing a daunting challenge within
the context of double burden and limited resources in the
developing world [6].
Since pre-eclampsia’s etiology remains unknown [7], investiga-
tion and identification of the most important risk factors is vital for
policy and clinical purposes including prioritization of interven-
tions, resource allocation, identification of high-risk pregnant
women for more intensive observation and care, and development
or improvement of risk management strategies. While most studies
have been undertaken in high-income settings, some inconsisten-
cies exist (e.g. whether or not maternal education is a significant
risk factor), especially in developing settings where pre-eclampsia
risk factors have been explored less. Furthermore, other conditions
such as maternal infections, severe anemia and lack of antenatal
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care that are more prevalent in less developed regions require
further investigation and validation of findings [8–10]. In addition,
previous research has been limited by small sample sizes [11] or
analytic methods that do not properly take into account the effects
of higher-level factors [12,13].
As for pre-eclampsia’s adverse maternal and perinatal out-
comes, there is limited information and research assessing the
magnitude of risks in low-resource areas where the impact is
thought to be more severe [14]. Furthermore, small sample sizes
or lack of adjustment for some important confounders are notable
weaknesses that have restricted previous research [11,15].
This study thus aimed to conduct multi-level analyses of data
from the WHO Global Survey on Maternal and Perinatal Health
including 23 developing countries in Africa, Latin America and
Asia in order to estimate associations between maternal, country
characteristics and pre-eclampsia/eclampsia, and to estimate the
magnitude of risks for pre-eclampsia/eclampsia’s adverse maternal
and perinatal outcomes.
Methods
Ethics Statement
The protocol was approved by the WHO’s Scientific and
Ethical Review Group and Ethics Review Committee and that of
each country independently [16]. Written consent was obtained
from each participating country’s ministry of health and each
selected facility’s director [16]. Because the study involved cluster-
level inclusion and records data extraction without individual
identifying information, individual informed consent was not
obtained.
Study design
We undertook a secondary analysis of the WHO Global Survey
on Maternal and Perinatal Health. Details of this survey’s
methodology are available elsewhere [16]. To summarize, the
survey was a multi-country, facility-based cross-sectional study. It
was conducted between 2004 and 2005 in Africa and Latin
America, and between 2007 and 2008 in Asia. A global sample of
countries and health facilities was obtained via a stratified
multistage cluster sampling design. Twenty-four countries from
three regions were included in the survey: Algeria, Angola,
Democratic Republic of Congo, Niger, Nigeria, Kenya, and
Uganda from Africa; Argentina, Brazil, Cuba, Ecuador, Mexico,
Nicaragua, Paraguay, and Peru from Latin America; and
Cambodia, China, India, Japan, Nepal, Philippines, Sri Lanka,
Thailand, and Vietnam from Asia. For each country, the capital
city and two randomly selected provinces were included in the
sample. Only health facilities with caesarean section (C-section)
capacities and with reported annual deliveries of at least 1,000
were eligible for inclusion. Up to seven facilities per country were
randomly selected. A total of 373 facilities were included in the
survey. The recruitment and data collection period varied
depending on the volume of deliveries in the sampled facilities.
Specifically, it was set for three months for facilities with up to
6,000 annual deliveries and two months for those with more than
6,000 annual deliveries. All pregnant women admitted for delivery
during the recruitment period were included.
Data Sources
Data for individuals and institutions were sourced from the
WHO Global Survey on Maternal and Perinatal Health.
Individual data were obtained via direct extraction from patient
records by trained medical personnel within seven days after
delivery or before maternal hospital discharge. Institutional data
were collected using a standard form by hospital coordinators in
consultation with the director or head of obstetrics, and country
information was obtained from the World Bank [17] and literature
[18].
Main Outcomes Variable Definitions
Due to secondary data limitations and based on previous
research [13] pre-eclampsia and its complication, eclampsia, were
combined into a single outcome variable. Pre-eclampsia was
defined as high blood pressure ($140 mmHg systolic or
$90 mmHg diastolic, or increases of 30 mmHg systolic or
15 mmHg diastolic from the baseline on at least two occasions
six or more hours apart) that develops from the 20th gestational
week in a previously normotensive woman, and proteinuria. The
outcome can be based on having the recorded diagnosis or on
blood pressure and urine test findings, even without specifying the
condition. Eclampsia was defined as the onset of convulsions
described as grand-mal type seizures first appearing before or
during labour, or within 48 hours from delivery, and/or coma
unrelated to other cerebral conditions in women with pre-
eclamptic signs and symptoms.
Adverse maternal and perinatal outcomes including maternal
death, perinatal death, preterm birth and low birthweight were
investigated. Maternal death was defined as intrahospital death of
a woman that occurred on or before the 8th day postpartum.
Perinatal death was defined as early neonatal death (i.e.
intrahospital death of an infant that occurred on or before the
7th day after delivery) or stillbirth (fresh or macerated). Preterm
birth was defined as livebirth occurring at less than 37 completed
gestational weeks and low birthweight was defined as birthweight
,2500 grams of a liveborn infant regardless of gestational age.
Independent Variables Definitions
The individual characteristics investigated were: maternal age,
marital status, maternal educational level, maternal body mass
index (BMI), parity, maternal clinical conditions (chronic hyper-
tension, gestational diabetes, cardiac/renal disease, pyelonephritis
or urinary infection, severe anemia) and number of antenatal
visits. Maternal age was defined as age in completed years at the
time of delivery. Participants were classified into four categories:
,20, 20 to 29, 30 to 34 and $35 years. Marital status was
dichotomized into single/widowed/divorced/separated and mar-
ried/cohabiting with the infant’s father. Maternal education was
based on the number of years of schooling. The UNESCO
international standard classification of education was adopted
allocating participants to one of five levels: no education (0 years),
primary (1 to 6 years), lower secondary (7 to 9 years), upper
secondary (10 to 12 years) and post-secondary/tertiary (.12
years).
Maternal BMI was computed as the ratio of maternal weight in
kilograms and the square of maternal height in meters. In Africa
and Latin America, maternal weight was recorded at the last
antenatal care visit, while in Asia, it was recorded at admission for
delivery. Maternal BMI was categorized into four ranges: ,20, 20
to ,26, 26 to ,35 and $35 kg/m2. Parity was defined as the
number of previous births and was dichotomized into nulliparity
and multiparity. Maternal clinical conditions were determined
based on the recorded diagnosis or laboratory findings, even
without specifying the condition. Chronic hypertension was
defined as high blood pressure diagnosed prior to the onset of
pregnancy or before the 20th gestational week. Severe anemia was
defined as a haemoglobin level of ,7 g/dL during pregnancy.
The number of antenatal visits was irrespective of whether the
antenatal clinic was different from the admission facility. This was
Pre-Eclampsia Risk Factors and Adverse Outcomes
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categorized into four based on WHO recommendations for
antenatal care: 0, 1 to 3, 4 to 8 and .8 visits.
Institutional Characteristics
We considered institutional information related to maternal and
perinatal care, such as: availability of laboratory tests; anesthesi-
ology resources; services for intrapartum care, delivery and
newborn care; and the presence of basic emergency medical and
obstetric care facilities, intensive care units, and training resources.
As with previous research using the WHO Global Survey data, we
applied institutional capacity index scoring to gauge facilities’
levels of resources as well as their maternal and perinatal care
service provision capabilities. Points were assigned for the
availability of resources or services and the unweighted total was
obtained. We then dichotomized the institutional capacity index
score into higher capacity (greater than the mean for all facilities)
and lower capacity (less than or equal to the mean for all facilities).
Country Characteristics
The country characteristics considered were gross national
income (GNI) per capita and maternal mortality ratio (MMR). We
categorized GNI per capita from the World Development
Indicators according to World Bank definitions of low income
($935 or less), lower-middle income ($936 to $3,705) and upper-
middle income ($3,706 to $11,455). MMRs (maternal deaths per
100,000 livebirths) were obtained from and followed The Lancet
series on maternal and child mortality’s categorization of low
(below 100), moderate (100 to 299), high (300 to 549) and very
high (550 and above) [18].
Study Population
The study population for the secondary analyses included
women with singleton neonates of at least 20 weeks of gestation.
Those with missing information on the inclusion criteria and on
the pre-eclampsia outcome were excluded. Japan was also
excluded due to the study’s focus on developing settings.
Statistical Analysis
Statistical analyses were conducted using Stata/MP version 12.1
(Stata Corp LP, College Station, Texas). Descriptive statistics (i.e.
proportions) to examine the distribution of the outcomes and
independent variables were generated. Univariate logistic regres-
sion analyses were also conducted for initial inspection of the
associations between the outcomes and independent variables. For
the main objectives, multi-level multiple regression modelling was
applied. In general, this involved three levels corresponding to the
individual, institutional and country characteristics with random
effects at the facility and country levels to account for unmeasured
higher-level factors and for clustering due to the sampling design.
Significance testing for random effects was conducted via
likelihood ratio tests which involved comparing nested models
with models that included additional higher levels. A p-value of
,0.05 was considered statistically significant. For the associations
between pre-eclampsia/eclampsia and the individual, institutional
and country characteristics, a single logistic model was employed
to simultaneously estimate the relationship of the independent
variables with the outcome. To estimate associations of pre-
eclampsia/eclampsia with adverse maternal and perinatal out-
comes, we created separate logistic regression models for each of
the adverse outcomes and adjusted for important confounders
identified from literature and the results of the previous risk factor
analysis. Two types of sensitivity analyses were conducted for all
models to address missing BMI information (.10% for a number
of countries) by: a) including a missing category for BMI and b)
excluding countries with more than 10% of BMI data missing,
namely: Kenya (86%), Brazil (67%), Angola (40%), Argentina
(32%), Uganda (22%), Philippines (20%), and Peru (13%).
Results
The WHO Global Survey on Maternal and Perinatal Health
dataset included a total of 290,610 deliveries. For this secondary
analysis, data for 276,388 mothers and their infants was retained
after excluding Japan, multiple births, deliveries at less than 20
weeks of gestation and those with missing information on the
inclusion criteria and pre-eclampsia/eclampsia outcome. Overall
and regional profiles for the study population are provided in
Table 1. The majority of mothers were aged between 20 to 29
years old (59%), were married or cohabiting with the infant’s
father (86%) or had given birth previously (57%). As for education
and BMI, the upper secondary level (37%) and the 20 to ,26 kg/
m2 (48%) category had the greatest proportions of mothers
respectively. At the facility level, the majority (65%) of deliveries
was in institutions with higher capacity index scores except for
Africa, where a greater portion (63%) of mothers delivered in
lower-capacity facilities. At the country level, the greatest
proportions were in the lower-middle GNI per capita category
(49%) and the low MMR level (60%) overall, but these
characteristics varied across regions.
The prevalence of pre-eclampsia/eclampsia in the study
population was 10,754 (4%), but there was much variation
between and within countries. Regional, country and facility pre-
eclampsia/eclampsia prevalence profiles are provided in Table 2
and Figure 1. Across regions, pre-eclampsia/eclampsia prevalenc-
es at the country level ranged from less than 1% in Angola to 8%
in Brazil. Such variability was also observed among countries
within the same region. The highest maternal mortality was
observed in Nigeria at 8 (3%), and the highest perinatal mortality
was in the Democratic Republic of Congo at 44 (22%) associated
with pre-eclampsia/eclampsia. The highest prevalence of preterm
birth was Angola at 35 (76%) and the highest rate of low
birthweight was in Sri Lanka at 83 (40%) associated with pre-
eclampsia/eclampsia.
Overall and regional profiles for pre-eclampsia/eclampsia risk
factors are provided in Table 1. Table 3 shows the adjusted odds-
ratios (AOR) for pre-eclampsia/eclampsia risk factors obtained via
multi-level multiple logistic regression analyses. At the individual
level, sociodemographic characteristics of older maternal age ($30
years), lower than secondary education attainment such as primary
level (AOR: 1.11; 95% confidence interval (CI): 1.01–1.22) or no
education (AOR: 1.22; 95%CI 1.07–1.39), high BMI ($26 kg/
m2) ($35 kg/m2, AOR: 3.90; 95%CI 3.52–4.33), nulliparity
(AOR: 2.04; 95%CI 1.92–2.16), were significantly associated with
higher odds of having pre-eclampsia/eclampsia. As for clinical
variables, history of chronic hypertension (AOR: 7.75; 95%CI
6.77–8.87), gestational diabetes (AOR: 2.00; 95%CI 1.63–2.45),
cardiac or renal disease (AOR: 2.38; 95%CI 1.86–3.05),
pyelonephritis or urinary tract infection (AOR: 1.13; 95%CI
1.03–1.24) and severe anemia (AOR: 2.98; 95%CI 2.47–3.61)
were also significantly associated with higher pre-eclampsia/
eclampsia risks. Antenatal care non-attendance was associated
with significantly higher pre-eclampsia/eclampsia risks (AOR:
1.41; 95%CI 1.26–1.57) while having .8 visits was protective
(AOR: 0.90; 95%CI 0.83–0.98). Lastly at the country level, a
significant increasing trend in pre-eclampsia/eclampsia odds was
observed with rising GNI per capita. Similar findings were
obtained from the sensitivity analyses.
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Table 1. Overall and regional distribution of risk factors for pre-eclampsia/eclampsia.
Characteristic Deliveries Pre-eclampsia/eclampsia
N % n %
Individual
Maternal age
,20 34,824 12.6 1,491 4.3
20 to 29 162,466 58.9 5,531 3.4
30 to 34 49,117 17.8 2,022 4.1
.= 35 29,461 10.7 1,696 5.8
Marital status
Single/divorced/separated/widowed/other 37,356 13.6 1,945 5.2
Married/cohabiting 238,193 86.4 8,764 3.7
Education
None 20,735 8.8 602 2.9
Primary 54,813 23.4 2,345 4.3
Lower secondary 35,370 15.1 1,276 3.6
Upper secondary 87,574 37.4 3,551 4.0
Post-secondary/tertiary 35,881 15.3 1,462 4.1
BMI (kg/m2)
,20 7,707 3.3 156 2.0
20 to ,26 111,049 47.7 2,803 2.5
26 to ,35 105,905 45.5 4,737 4.5
.= 35 8,221 3.5 888 10.8
Parity
Nulliparous 118,348 43.0 5,527 4.7
Multiparous 156,589 57.0 5,178 3.3
Chronic hypertension
Yes 2,334 0.8 653 28.0
No 273,769 99.2 10,093 3.7
Gestational diabetes
Yes 1,940 0.7 204 10.5
No 274,163 99.3 10,544 3.8
Cardiac/renal disease
Yes 1,254 0.4 151 12.0
No 274,848 99.6 10,597 3.9
Pyelonephritis/urinary tract infection
Yes 18,230 6.6 1,169 6.4
No 257,825 93.4 9,574 3.7
Severe anemia
Yes 1,529 0.6 192 12.6
No 274,555 99.4 10,555 3.8
Antenatal care visits
0 12,750 5.2 689 5.4
1 to 3 67,124 27.4 2,217 3.3
4 to 8 127,162 52.0 5,088 4.0
.8 37,658 15.4 1,556 4.1
Institutional
Facility capacity
Lower 96,723 35.0 2,112 2.2
Higher 179,665 65.0 8,642 4.8
Country
Pre-Eclampsia Risk Factors and Adverse Outcomes
PLOS ONE | www.plosone.org 4 March 2014 | Volume 9 | Issue 3 | e91198
Table 1. Cont.
Characteristic Deliveries Pre-eclampsia/eclampsia
N % n %
GNI per capita
Low 83,915 30.4 2,045 2.4
Lower-middle 134,280 48.6 5,185 3.9
Upper-middle 58,193 21.0 3,524 6.1
Maternal mortality ratio
Low 166,660 60.3 7,272 4.4
Moderate 47,117 17.0 1,880 4.0
High 57,217 20.7 1,556 2.7
Very high 5,394 2.0 46 0.8
doi:10.1371/journal.pone.0091198.t001
Table 2. Distribution of pre-eclampsia and its adverse maternal and perinatal outcomes in the study population by region and
country.
Region Country All Deliveries Pre-eclampsia
Deliveries Maternal death Perinatal death Preterm birth Low birthweigh
N n % n % n % n % n %
Africa 77,884 1,804 2.32 25 1.39 296 16.46 469 26.71 400 23.92
Algeria 15,273 202 1.32 1 0.50 23 11.39 53 27.32 63 36.00
Angola 5,394 46 0.85 1 2.17 8 17.39 35 76.09 10 21.74
DRC* 8,404 199 2.37 8 4.0 44 22.11 33 17.10 35 18.13
Kenya 18,767 506 2.70 3 0.59 99 19.6 161 32.33 158 32.58
Niger 8,123 88 1.08 1 1.14 12 13.64 11 12.79 19 22.35
Nigeria 8,699 271 3.12 8 2.97 53 19.56 84 31.94 54 22.41
Uganda 13,224 492 3.72 3 0.61 57 11.70 92 19.33 31 21.38
Latin America 95,296 5,718 6.00 3 0.05 186 3.26 1,176 20.96 1,285 23.56
Argentina 10,335 334 3.23 NR 6 1.80 93 28.01 91 28.89
Brazil 14,625 1,203 8.23 1 0.08 35 2.94 200 16.82 242 21.30
Cuba 12,521 477 3.81 NR 19 3.98 83 17.89 89 20.05
Ecuador 12,310 818 6.65 1 0.12 14 1.71 97 12.28 160 20.20
Mexico 20,712 1,510 7.29 1 0.07 51 3.38 381 25.73 364 25.26
Nicaragua 5,599 256 4.57 NR 10 3.91 38 15.28 51 20.65
Paraguay 3,374 166 4.92 NR 11 6.67 44 26.67 40 25.64
Peru 15,820 954 6.03 NR 40 4.19 240 25.48 248 27.49
Asia 103,208 3,232 3.13 22 0.68 307 9.48 868 27.26 1,090 34.45
Cambodia 5,458 155 2.84 1 0.64 20 12.82 48 31.37 52 34.67
China 14,373 402 2.80 1 0.25 13 3.23 81 20.66 76 20.27
India 24,421 1,123 4.60 14 1.25 177 15.76 391 35.07 444 39.71
Nepal 8,265 180 2.18 2 1.08 20 10.75 43 24.43 69 38.12
Philippines 13,169 738 5.60 4 0.54 60 8.13 146 20.17 244 33.56
Sri Lanka 14,891 208 1.40 NR 10 4.81 68 32.69 83 39.90
Thailand 9,656 272 2.82 NR 5 1.84 70 25.93 91 35.00
Vietnam 12,975 154 1.19 NR 2 1.30 21 14.38 61 13.65
*Democratic Republic of Congo; NR- not reported.
doi:10.1371/journal.pone.0091198.t002
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For adverse maternal and perinatal outcomes, overall preva-
lences were less than 335 (1%) for maternal death, 7,404 (3%) for
perinatal death, 27,611 (10%) for preterm birth and 27,348 (10%)
for low birthweight. Prevalences of the adverse outcomes by region
and country are given in Table 2. Table 4 provides the adjusted
odds-ratios for adverse maternal and perinatal outcomes obtained
via multi-level logistic regression analyses. Random effects for the
institutional and country levels in each model were shown to be
significant from likelihood-ratio tests. For maternal death (AOR:
4.48; 95%CI 2.99–6.69) and perinatal death (AOR: 1.87; 95%CI
1.66–2.11), preterm birth (AOR: 2.86; 95%CI 2.68–3.06) and low
birthiweight (AOR: 2.32; 95%CI 2.16–2.50), pre-eclampsia/
eclampsia was found to be a significant risk factor. Similar
findings were obtained from the sensitivity analyses.
Discussion
To the authors’ knowledge, this is the first multi-level, multi-
country analyses dealing with pre-eclampsia/eclampsia risk factors
and its adverse outcomes including maternal deaths focusing on
developing settings. Also among the strengths of this study are the
large sample size and the application of standardized question-
naires across facilities, countries and regions. The prevalences of
pre-eclampsia/eclampsia in the study population showed consid-
erable variation at both the country and facility levels. At the
individual level, a history of chronic hypertension, a BMI$35 kg/
m2, and severe anemia significantly increased the risk of pre-
eclampsia/eclampsia by three times or more. Other significant
higher maternal risk factors (twice the odds or greater) included
having cardiac or renal disease, having diabetes, being nulliparous
and being $30 years of age. Mothers diagnosed with pre-
eclampsia/eclampsia were found to be significantly at four times
the risk of maternal death than mothers who did not have pre-
eclampsia/eclampsia. Our analysis found that protective factors
for preeclampsia/eclampsia included .8 antenatal care visits
compared with 4–8 visits. The MMR was found to be significantly
associated with pre-eclampsia/eclampsia risk factors. The condi-
tion was also shown to have a higher risk for perinatal death,
preterm birth and low birth weight. These findings support
previous research [3,4].
The variation of pre-eclampsia/eclampsia prevalences is per-
haps not only reflective of the variability in maternal risk-factor
distribution, but may also be attributed to differences in facility
and country characteristics, such as diagnostic capacities or
accessibility of services. While the facility’s referral level is also a
factor, considerable variability was still observed even after
stratification on this variable. The above observations are
supported by findings that GNI per capita are significant pre-
eclampsia/eclampsia risk factors. This may be explained by
countries with lower GNI per capita having less diagnostic
capabilities to identify pre-eclampsia/eclampsia cases. Lower GNI
per capita may also be reflective of socioeconomic factors
associated with poor access to healthcare services. These findings
suggest probable underestimation of pre-eclampsia/eclampsia
prevalences in low-resource settings as well as failure to identify
high-risk pregnant women for proper management, potentially
Figure 1. Pre-eclampsia prevalence per facility by country and region. Plot showing prevalence of pre-eclampsia per facility by country and
region (Africa, Asia and Latin America).
doi:10.1371/journal.pone.0091198.g001
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Table 3. Adjusted odds ratios (ORs) of risk factors for pre-eclampsia/eclampsia.
Risk factor Adjusted OR (95% CI) p-value
Individual
Maternal age
,20 0.97 (0.89–1.05) 0.458
20 to 29 Ref
30 to 34 1.40 (1.31–1.51) ,0.001
.= 35 1.95 (1.80–2.12) ,0.001
Marital status
Single/divorced/separated/widowed/other 0.98 (0.90–1.06) 0.577
Married/cohabiting Ref
Education
None 1.22 (1.07–1.39) 0.003
Primary 1.11 (1.01–1.22) 0.033
Lower secondary 1.05 (0.95–1.17) 0.347
Upper secondary 1.06 (0.98–1.15) 0.172
Post-secondary/tertiary Ref
BMI (kg/m2)
,20 0.86 (0.72–1.03) 0.105
20 to ,26 Ref
26 to ,35 1.71 (1.61–1.81) ,0.001
.= 35 3.90 (3.52–4.33) ,0.001
Parity
Nulliparous 2.04 (1.92–2.16) ,0.001
Multiparous Ref
History of chronic hypertension
Yes 7.75 (6.77–8.87) ,0.001
No Ref
Gestational diabetes
Yes 2.00 (1.63–2.45) ,0.001
No Ref
Cardiac/renal disease
Yes 2.38 (1.86–3.05) ,0.001
No Ref
Pyelonephritis/urinary tract infection
Yes 1.13 (1.03–1.24) 0.007
No Ref
Severe anemia
Yes 2.98 (2.47–3.61) ,0.001
No Ref
Antenatal care visits
0 1.41 (1.26–1.57) ,0.001
1 to 3 1.01 (0.94–1.08) 0.752
4 to 8 Ref
.8 0.90 (0.83–0.98) 0.017
Institutional
Facility capacity
Lower 0.47 (0.37–0.60) ,0.001
Higher Ref
Country
GNI per capita
Low Ref
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leading to increased incidence of adverse outcomes. Implications
thus include improvement in diagnostic capabilities and in
accessibility to healthcare services. Additionally, the significant
association of moderate maternal mortality with higher pre-
eclampsia/eclampsia risk compared to low maternal mortality
may be reflective of other factors that have not been explored in
this study and warrant further investigation.
The three highest risk factors for pre-eclampsia/eclampsia at
the individual level were a history of chronic hypertension, high
maternal BMI and severe anemia. Other risk factors included the
clinical conditions of having cardiac or renal disease and having
diabetes as well as obstetric characteristics of nulliparity and older
maternal age. The above findings corroborate and add to previous
research conducted in developed and in developing settings
[11,13,19]. The associations between these risk factors and pre-
eclampsia/eclampsia may be explained by various proposed
pathophysiologic pathways. For the interrelated conditions of
high BMI, hypertension and diabetes, the accompanying insulin
resistance and hypertriglyceridemia have been suggested to
contribute to the endothelial dysfunction linked to pre-eclampsia
incidence [11,13]. A systematic review conducted in 2005 [19]
assessed controlled studies published over the period 1966–2002
and aimed to determine the risk of pre-eclampsia associated with
factors that may be detected at antenatal check-ups. The review
did not include severe anemia as a risk factor, despite the inclusion
of a higher BMI and a history of pre-eclampsia [19]. A
retrospective case-control study at eastern Sudan’s Kassala
hospital is the only study to show that women with severe anemia
(,7 g/dl) had a 3.6 times significantly higher risk of pre-eclampsia
compared to women with no anemia [8]. This study was based on
data from only one hospital, whereas our study is the first to
confirm the association between severe anemia and pre-eclamp-
sia/eclampsia using a large global dataset.The associated micro-
nutrient and antioxidant deficiencies are probable contributors to
the development of pre-eclampsia/eclampsia. For the obstetric risk
factors of nulliparity and older maternal age, several hypotheses
involving maternal immune maladaptation [11,13], and aging-
mediated vascular damage [11,13,19] have been proposed
respectively. Since all the above risk factors can be identified
during antenatal check-ups, risk screening and the referral of
higher-risk pregnancies for more intensive care at the check-up
stage could help reduce the incidence of pre-eclampsia/eclampsia
or its adverse outcomes. These corroborate hypotheses from
previous research in developing settings proposing achievement of
pre-eclampsia risk reduction via provision of opportune and
effective antenatal care through a well-functioning health system
[20,21]. This then necessitates improving the availability, acces-
sibility and quality of maternal healthcare facilities and services,
thus reiterating the call to strengthen primary health care and
health systems. Moreover, the risks posed by hypertension, high
BMI, and diabetes calls attention to the less-recognized interaction
of such conditions with maternal health [6]. Given that pre-
eclampsia/eclampsia has been linked to increased risks of future
chronic diseases as well and with the growing burden of non-
communicable diseases (NCDs) in developing settings [6] joint
efforts that encompass the areas of maternal health and NCDs
should be explored, especially in settings with limited resources.
Additional significant risk factors were antenatal care non-
attendance, attaining less than a secondary level of education and
having pyelonephritis or urinary tract infection. These findings
support some previous research [19,22] but disagree with others,
especially regarding education as a significant risk factor [11,13].
The increased risks of having pre-eclampsia/eclampsia with no
antenatal care attendance may be explained by inadequate
management during pregnancy to prevent development of the
condition. Low educational attainment on the other hand, may be
indirectly representative of low socioeconomic status and its
associated socioeconomic determinants, which could contribute to
pre-eclampsia development [23]. Poor access to care, for instance,
could lead to inadequate prenatal management and ultimately
pre-eclampsia/eclampsia. As for risks associated with pyelone-
phritis or urinary tract infection, there are various hypotheses
involving cardiovascular pathways and inflammatory responses
among others. The risks posed by lack of antenatal care and a low
level of education call attention to the social determinants of
Table 3. Cont.
Risk factor Adjusted OR (95% CI) p-value
Lower-middle 2.04 (1.03–4.02) 0.040
Upper-middle 3.55 (1.57–8.02) 0.002
Maternal mortality ratio
Low Ref
Moderate 1.97 (1.11–3.48) 0.020
High 1.73 (0.78–3.84) 0.180
Very high 0.50 (0.16–1.55) 0.231
Three-level structure logistic random effects regression models were used to obtain the Adjusted ORs: individual (level 1); facility (level 2); and country (level 3) adjusted
with variables in the table.
doi:10.1371/journal.pone.0091198.t003
Table 4. Adjusted odds ratios (ORs) for adverse maternal and
perinatal outcomes of pre-eclampsia.
Adverse outcome Adjusted OR (95% CI) p-value
Maternal death 4.48 (2.99–6.69) ,0.001
Perinatal deatha, b 1.87 (1.66–2.11) ,0.001
Preterm birtha 2.86 (2.68–3.06) ,0.001
Low birthweighta, b 2.32 (2.16–2.50) ,0.001
Adjusted for facility capacity index score at facility level, GNI per capita and
maternal mortality ratio at the country level, marital status, maternal education,
maternal age, maternal BMI, parity, clinical conditions (hypertension, diabetes,
cardiac/renal disease, pyelonephritis or urinary infection, severe anemia) and
number of antenatal care visits at the individual level.
aAlso adjusted for infant sex.
bAlso adjusted for gestational age.
doi:10.1371/journal.pone.0091198.t004
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maternal health and reiterate the need to improve availability,
utilization and quality of maternal healthcare facilities and
services. On the other hand, maternal infection as a risk factor
of pre-eclampsia/eclampsia requires further exploration and
validation. The above findings also suggest that maternal health
should not be viewed as a separate issue, but that it should be
incorporated in a more comprehensive perspective and approach,
especially in the context of double burden in low-resource settings
[6].
This study has several limitations. First, being facility-based, the
findings may not be generalizable to the broader population,
especially in settings where institutional delivery rates are low.
Second, there are potential biases and errors arising from the
dataset. Although efforts were undertaken to standardize the data,
logistical considerations and differences in medical protocols or
clinical practices in the various facilities and settings precluded
complete standardization. Also, because the study was not
originally designed to detect pre-eclampsia/eclampsia and its
outcomes or to screen for risk factors, underdiagnoses or likelier
detection of more clinically evident cases could have transpired.
On the other hand, missing BMI information could have biased
our estimates, but the similarity of results from several sensitivity
analyses suggests that this is probably not a major limitation.
However, the BMI variable could contain heterogenous informa-
tion because of the inconsistent timing of weight measurements in
different settings. Furthermore, residual confounding probably
exists in our estimates, especially with regards to the effects of
smoking. Maternal smoking status could not be controlled for due
to the absence of data, although it should be noted that previous
research has found smoking to be a protective factor for pre-
eclampsia/eclampsia and thus the magnitude of association from
our study is probably biased towards the null. Lastly, perinatal
mortality in our study only includes intrahospital deaths, and the
inability to capture post-discharge mortality implies that our
results could be underestimated. Interpretation of results should
thus consider all the above limitations.
Conclusions
In low- and middle-income settings, pre-eclampsia/eclampsia is
significantly associated with maternal death, perinatal death,
preterm birth and low birthweight. At the individual level, a
number of sociodemographic and medical variables are significant
risk factors for pre-eclampsia/eclampsia, with chronic hyperten-
sion, obesity and severe anemia posing the highest risks of the
outcome, and with .8 antenatal care visits acting as a protective
factor. Implementation of effective interventions targeting risk
factors, provision of quality health services and joint efforts in the
areas of maternal health are recommended. Prevention, early
detection and timely management of pre-eclampsia/eclampsia and
its risk factors at antenatal care visits have the potential to deliver
considerable improvement in maternal and perinatal health in
low- and middle-income settings.
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